Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 835 (ZNF835) is a member of the C2H2-type zinc finger transcription factors, proteins characterized by the presence of zinc finger domains that bind DNA in a sequence-specific manner and regulate transcription. ZNF835 is predicted to function as a DNA-binding transcription factor involved in the regulation of transcription by RNA polymerase II. It is localized in the nucleus and may participate in gene regulatory networks, though its specific targets and biological effects remain largely uncharacterized. There are no currently identified diseases directly associated with ZNF835, and it is not known to be a drug target, biomarker, or to present safety concerns. Aliases for ZNF835 include BC37295_3. Its relevance presently lies mainly in basic molecular biology rather than clinical application.
Not applicable; no drugs target this molecule directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 835 (ZNF835).